Abstract
Children with problematic asthma represent about 0.5% of the population but consume a disproportionate amount of healthcare staff time and resources. The most important step in managing children with problematic asthma is differentiating those with genuine severe, therapy resistant disease from those who have difficult to treat asthma for a variety of other remediable factors. The most common causes of poor symptom control are poor adherence to therapy, ongoing exposure to sensitized allergens or co-morbid psychosocial problems. In up to half of the children with problematic asthma, addressing these simple factors can avoid further escalation of treatment or more invasive investigation. All asthmatic children with poor control despite treatment with ≥ 800μg of inhaled budesonide (or equivalent) should be referred to a paediatric respiratory specialist for evaluation. Management of children with problematic asthma, and particularly those with genuine severe therapy resistant disease, requires a stepwise multidisciplinary approach.
Keywords: Asthma, problematic, severe, difficult, adherence, steroid-sparing
Current Pediatric Reviews
Title: Severe Asthma: Why do Some Children Not Respond to Treatment?
Volume: 6 Issue: 2
Author(s): Ruth O'Reilly and Sejal Saglani
Affiliation:
Keywords: Asthma, problematic, severe, difficult, adherence, steroid-sparing
Abstract: Children with problematic asthma represent about 0.5% of the population but consume a disproportionate amount of healthcare staff time and resources. The most important step in managing children with problematic asthma is differentiating those with genuine severe, therapy resistant disease from those who have difficult to treat asthma for a variety of other remediable factors. The most common causes of poor symptom control are poor adherence to therapy, ongoing exposure to sensitized allergens or co-morbid psychosocial problems. In up to half of the children with problematic asthma, addressing these simple factors can avoid further escalation of treatment or more invasive investigation. All asthmatic children with poor control despite treatment with ≥ 800μg of inhaled budesonide (or equivalent) should be referred to a paediatric respiratory specialist for evaluation. Management of children with problematic asthma, and particularly those with genuine severe therapy resistant disease, requires a stepwise multidisciplinary approach.
Export Options
About this article
Cite this article as:
O'Reilly Ruth and Saglani Sejal, Severe Asthma: Why do Some Children Not Respond to Treatment?, Current Pediatric Reviews 2010; 6 (2) . https://dx.doi.org/10.2174/157339610791561150
DOI https://dx.doi.org/10.2174/157339610791561150 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Regulation of Granulocyte Apoptosis by Hemopoietic Growth Factors, Cytokines and Drugs: Potential Relevance to Allergic Inflammation
Current Drug Targets - Inflammation & Allergy Foreword: The Year in Review: Comments on Plants, Cyclodextrins, Microbiota, and Diabetes
Current Pharmaceutical Design Synthesis of Novel Imine Stilbene Analogs Exhibiting Potent Anticancer Activity
Anti-Cancer Agents in Medicinal Chemistry EMT Blockage Strategies: Targeting Akt Dependent Mechanisms for Breast Cancer Metastatic Behaviour Modulation
Current Gene Therapy Structure-Based Drug Design of Novel MARK-3 Inhibitors in Cancer
Current Bioactive Compounds Citrus Essential Oils: Current and Prospective Uses in the Food Industry
Recent Patents on Food, Nutrition & Agriculture Chalcones Incorporated Pyrazole Ring Inhibit Proliferation, Cell Cycle Progression, Angiogenesis and Induce Apoptosis of MCF7 Cell Line
Anti-Cancer Agents in Medicinal Chemistry Optimizing Contrast Effect in T1-Weighted Magnetic Resonance Imaging of Gd2O3-Based Nano-Agent via Dopamine Chelation
Neuroscience and Biomedical Engineering (Discontinued) Design and Synthesis of Quinazolinone Derivatives as Anti-inflammatory Agents: Pharmacophore Modeling and 3D QSAR Studies
Medicinal Chemistry CD36-TSP-HRGP Interactions in the Regulation of Angiogenesis
Current Pharmaceutical Design Monoclonal Antibody Therapies Targeting Pancreatic Ductal Adenocarcinoma
Current Drug Discovery Technologies Monoclonal Antobodies: Application in Radiopharmacy
Current Radiopharmaceuticals Characterization and Antihypertensive Effect of the Complex of (-)-β- pinene in β-cyclodextrin
Current Pharmaceutical Biotechnology Selected Heterocyclic Compounds as Antioxidants. Synthesis and Biological Evaluation
Current Topics in Medicinal Chemistry Taking Cell Culture in Drug Discovery to the Third Dimension - A Patent Review
Recent Patents on Biomedical Engineering (Discontinued) Role of the Decreased Nitric Oxide Bioavailability in the Vascular Complications of Diabetes Mellitus
Current Pharmaceutical Biotechnology Role of Lipoxins and Resolvins as Anti-Inflammatory and Proresolving Mediators in Colon Cancer
Current Molecular Medicine cGMP-Dependent Protein Kinase in Regulation of the Pulmonary Circulation
Current Respiratory Medicine Reviews Pulmonary Hypertension in COPD: Pathophysiology and Therapeutic Targets
Current Drug Targets Recent Patents on Drugs Addressing Neurodegenerative Diseases
Recent Patents on Biomarkers